Immunovant (IMVT) Shares Issued (2019 - 2026)

Immunovant has reported Shares Issued for 8 years, with the latest figure at $495.7 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued rose 11.11% year-over-year to $495.7 million; the trailing twelve-month figure through Mar 2026 stood at $544.2 million (up 20.93% YoY), and the FY2026 full-year result was $544.2 million, up 20.93% from the prior year.
• Shares Issued for Q1 2026 stood at $495.7 million, up from $21.0 million in the prior quarter.
• The five-year high for Shares Issued was $495.7 million in Q1 2026, with the low at -$69.8 million in Q1 2023.
• Historically, Shares Issued has averaged $97.8 million across 5 years, with a median of $2.9 million in 2025.
• The largest YoY upside for Shares Issued was 4138.1% in 2023 against a maximum downside of 95.59% in 2023.
• Immunovant's Shares Issued stood at $70.5 million in 2022, then plunged by 95.59% to $3.1 million in 2023, then decreased by 20.8% to $2.5 million in 2024, then surged by 752.07% to $21.0 million in 2025, then jumped by 2260.97% to $495.7 million in 2026.
• The last three Shares Issued figures came in at $495.7 million (Q1 2026), $21.0 million (Q4 2025), and $24.6 million (Q3 2025), per Business Quant data.